Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Effect of Alert Level 4 on Reff: review of international COVID-19 cases

View ORCID ProfileRachelle N. Binny, View ORCID ProfileShaun C. Hendy, View ORCID ProfileAlex James, View ORCID ProfileAudrey Lustig, View ORCID ProfileMichael J. Plank, Nicholas Steyn
doi: https://doi.org/10.1101/2020.04.30.20086934
Rachelle N. Binny
1Manaaki Whenua, Lincoln, New Zealand
4Te Pūnaha Matatini: the Centre for Complex Systems and Networks, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rachelle N. Binny
  • For correspondence: binnyr@landcareresearch.co.nz
Shaun C. Hendy
3Department of Physics, University of Auckland, New Zealand
4Te Pūnaha Matatini: the Centre for Complex Systems and Networks, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Shaun C. Hendy
Alex James
2School of Mathematics and Statistics University of Canterbury, New Zealand
4Te Pūnaha Matatini: the Centre for Complex Systems and Networks, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alex James
Audrey Lustig
1Manaaki Whenua, Lincoln, New Zealand
4Te Pūnaha Matatini: the Centre for Complex Systems and Networks, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Audrey Lustig
Michael J. Plank
2School of Mathematics and Statistics University of Canterbury, New Zealand
4Te Pūnaha Matatini: the Centre for Complex Systems and Networks, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael J. Plank
Nicholas Steyn
2School of Mathematics and Statistics University of Canterbury, New Zealand
3Department of Physics, University of Auckland, New Zealand
4Te Pūnaha Matatini: the Centre for Complex Systems and Networks, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

The effective reproduction number, Reff, is an important measure of transmission potential in the modelling of epidemics. It measures the average number of people that will be infected by a single contagious individual. A value of Reff > 1 suggests that an outbreak will occur, while Reff < 1 suggests the virus will die out. In response to the COVID-19 pandemic, countries worldwide are implementing a range of intervention measures, such as population-wide social distancing and case isolation, with the goal of reducing Reff to values below one, to slow or eliminate transmission. We analyse case data from 25 international locations to estimate their Reff values over time and to assess the effectiveness of interventions, equivalent to New Zealand’s Alert Levels 1-4, for reducing transmission. Our results show that strong interventions, equivalent to NZ’s Alert Level 3 or 4, have been successful at reducing Reff below the threshold for outbreak. In general, countries that implemented strong interventions earlier in their outbreak have managed to maintain case numbers at lower levels. These estimates provide indicative ranges of Reff for each Alert Level, to inform parameters in models of COVID-19 spread under different intervention scenarios in New Zealand and worldwide. Predictions from such models are important for informing policy and decisions on intervention timing and stringency during the pandemic.

Executive Summary

  • In response to the COVID-19 pandemic, countries around the world are implementing a range of intervention measures, such as population-wide social distancing and case isolation, with the goal of reducing the spread of the virus.

  • Reff, the effective reproduction number, measures the average number of people that will be infected by a single contagious individual. A value of Reff > 1 suggests that an outbreak will occur, while Reff < 1 suggests the virus will die out.

  • Comparing Reff in an early outbreak phase (no or low-level interventions implemented) with a later phase (moderate to high interventions) indicates how effective these measures are for reducing Reff.

  • We estimate early-phase and late-phase Reff values for COVID-19 outbreaks in 25 countries (or provinces/states). Results suggest interventions equivalent to NZ’s Alert Level 3-4 can successfully reduce Reff below the threshold for outbreak.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No external funding was received.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

This article does not present new data. Link to source of data used in analyses provided.

https://github.com/CSSEGISandData/COVID-19

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted May 06, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Effect of Alert Level 4 on Reff: review of international COVID-19 cases
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Effect of Alert Level 4 on Reff: review of international COVID-19 cases
Rachelle N. Binny, Shaun C. Hendy, Alex James, Audrey Lustig, Michael J. Plank, Nicholas Steyn
medRxiv 2020.04.30.20086934; doi: https://doi.org/10.1101/2020.04.30.20086934
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Effect of Alert Level 4 on Reff: review of international COVID-19 cases
Rachelle N. Binny, Shaun C. Hendy, Alex James, Audrey Lustig, Michael J. Plank, Nicholas Steyn
medRxiv 2020.04.30.20086934; doi: https://doi.org/10.1101/2020.04.30.20086934

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (227)
  • Allergy and Immunology (500)
  • Anesthesia (110)
  • Cardiovascular Medicine (1230)
  • Dentistry and Oral Medicine (205)
  • Dermatology (147)
  • Emergency Medicine (282)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (529)
  • Epidemiology (10005)
  • Forensic Medicine (5)
  • Gastroenterology (497)
  • Genetic and Genomic Medicine (2445)
  • Geriatric Medicine (236)
  • Health Economics (479)
  • Health Informatics (1635)
  • Health Policy (751)
  • Health Systems and Quality Improvement (633)
  • Hematology (248)
  • HIV/AIDS (531)
  • Infectious Diseases (except HIV/AIDS) (11855)
  • Intensive Care and Critical Care Medicine (625)
  • Medical Education (251)
  • Medical Ethics (74)
  • Nephrology (267)
  • Neurology (2273)
  • Nursing (139)
  • Nutrition (350)
  • Obstetrics and Gynecology (452)
  • Occupational and Environmental Health (532)
  • Oncology (1244)
  • Ophthalmology (375)
  • Orthopedics (133)
  • Otolaryngology (226)
  • Pain Medicine (154)
  • Palliative Medicine (50)
  • Pathology (324)
  • Pediatrics (729)
  • Pharmacology and Therapeutics (311)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2280)
  • Public and Global Health (4824)
  • Radiology and Imaging (833)
  • Rehabilitation Medicine and Physical Therapy (488)
  • Respiratory Medicine (650)
  • Rheumatology (283)
  • Sexual and Reproductive Health (237)
  • Sports Medicine (225)
  • Surgery (266)
  • Toxicology (44)
  • Transplantation (124)
  • Urology (99)